Physician profile
Daniel Jay Rudolph
NPI 1356335707
$2,255.23
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,645 · 2020: $388 · 2022: $20.45 · 2023: $15.53 · 2024: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $629.65 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $338.53 | 2019-2020 | |
| Baxter Healthcare | $201.78 | 2023-2024 | Hillrom - Vest System Model 105 Home Care |
| Boehringer Ingelheim Pharmaceuticals, INC. | $178.28 | 2019-2020 | |
| Insmed, INC. | $172.24 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $118.63 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $118.15 | 2019 | |
| Genentech USA, INC. | $108.46 | 2019-2020 | |
| Shire North American Group INC | $87.45 | 2019 | |
| Mallinckrodt Enterprises LLC | $50.50 | 2019 | |
| Electromed, INC. | $45.92 | 2019 | |
| Philips North America LLC | $44.73 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $40.79 | 2019 | |
| Mallinckrodt Hospital Products INC. | $38.37 | 2020 | |
| Janssen Pharmaceuticals, INC | $34.91 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $18.31 | 2019 | |
| Lilly USA, LLC | $15.00 | 2020 | |
| Nabriva Therapeutics, Plc | $13.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Rudolph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.